The biotech is a step closer to getting its therapy for drug-resistant infections to patients.
{iframe}https://www.bizjournals.com/washington/news/2019/10/08/gaithersburg-firm-taking-down-superbugs-just.html{/iframe}
Adaptive Phage Therapeutics raises $7M from Alexandria Venture Investments, others – Washington Business Journal
The biotech is a step closer to getting its therapy for drug-resistant infections to patients.
BioHealth Innovation, Inc. (BHI) is an innovation intermediary that translates market-relevant research into commercial success by connecting management, funding, and markets.
© 2025 BioHealth Innovation.
You have successfully subscribed to the newsletter
There was an error while trying to send your request. Please try again.